Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E M Griffiths

Showing results (181-190 of 281) with videos related to

Pageof 29
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2020
Diurnal and seasonal variation in psoriasis symptomsF J Ferguson, G Lada, H J A Hunter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2009
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL studyE Daudén, C E M Griffiths, J-P Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2021
Restoration of collagen and elastic fibre networks following treatment of photoaged skin with Serènesse, a novel over-the-counter anti-ageing productA K Langton, J C McConnell, L F Cotterell, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
The British Journal of Dermatology|May 15, 2009
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]R E B Watson, S Ogden, L F Cotterell, et al.
Clinical and Experimental Dermatology|October 24, 2020
An evaluation of dermatology patients shielding during the COVID-19 outbreakS S Khan, C L Marshall, K A Stylianou, et al.
The British Journal of Dermatology|September 24, 2017
Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studiesK B Gordon, A Blauvelt, P Foley, et al.
The British Journal of Dermatology|November 26, 2005
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasisH L Richards, D W Ray, B Kirby, et al.
The British Journal of Dermatology|January 23, 2018
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysisD E Stull, C E M Griffiths, I Gilloteau, et al.
The British Journal of Dermatology|May 15, 2021
Patient preferences for stratified medicine in psoriasis: a discrete choice experimentG Dalal, S J Wright, C M Vass, et al.
Pageof 29

Showing results (181-190 of 281) with videos related to

Sort By:
Pageof 29
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2020
Diurnal and seasonal variation in psoriasis symptomsF J Ferguson, G Lada, H J A Hunter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2009
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL studyE Daudén, C E M Griffiths, J-P Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2021
Restoration of collagen and elastic fibre networks following treatment of photoaged skin with Serènesse, a novel over-the-counter anti-ageing productA K Langton, J C McConnell, L F Cotterell, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
The British Journal of Dermatology|May 15, 2009
Effects of a cosmetic 'anti-ageing' product improves photoaged skin [corrected]R E B Watson, S Ogden, L F Cotterell, et al.
Clinical and Experimental Dermatology|October 24, 2020
An evaluation of dermatology patients shielding during the COVID-19 outbreakS S Khan, C L Marshall, K A Stylianou, et al.
The British Journal of Dermatology|September 24, 2017
Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studiesK B Gordon, A Blauvelt, P Foley, et al.
The British Journal of Dermatology|November 26, 2005
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasisH L Richards, D W Ray, B Kirby, et al.
The British Journal of Dermatology|January 23, 2018
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysisD E Stull, C E M Griffiths, I Gilloteau, et al.
The British Journal of Dermatology|May 15, 2021
Patient preferences for stratified medicine in psoriasis: a discrete choice experimentG Dalal, S J Wright, C M Vass, et al.
Pageof 29